FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Sulfasalazine Tablet
Status: Resolved
»Duration of Shortage: 04/24/2020 - 05/21/2024
»Therapeutic Categories: Gastroenterology

Expand all

Pfizer Inc. (Revised 05/21/2024)

Company Contact Information:
800-533-4535

Presentation

• Azulfidine, Tablet, 500 mg (NDC 0013-0101-10)
• Azulfidine, Tablet, 500 mg (NDC 0013-0101-20)
• Azulfidine, Tablet, 500 mg (NDC 0013-0102-50)
• Azulfidine, Tablet, 500 mg (NDC 0013-0102-20)
• Tablet, 500 mg (NDC 59762-0104-1)
• Tablet, 500 mg (NDC 59762-0104-6)
• Tablet, 500 mg (NDC 59762-5000-1)
• Tablet, 500 mg (NDC 59762-5000-6)
• Azulfidine, Tablet, 500 mg (NDC 0013-0101-30)
• Azulfidine, Tablet, 500 mg (NDC 0013-0102-60)
• Tablet, 500 mg (NDC 59762-0104-5)
• Tablet, 500 mg (NDC 59762-5000-5)

Note:

• N/A

Teva Pharmaceuticals USA, Inc. (Revised 05/21/2024)

Company Contact Information:
800-545-8800

Presentation

• Sulfasalazine Tablets, USP, Tablet, 500 mg (NDC 0093-3234-01)
• Sulfasalazine Tablets, USP, Tablet, 500 mg (NDC 0093-3234-10)
• Sulfasalazine Tablets, USP, Tablet, 500 mg (NDC 0093-3234-05)

Note:

• N/A